Lazard Growth Acquisition Corp. I
Status: Liquidated
U=S+W/5
W=S@11.5
| IPO Proceeds, $M | $575.00M |
|---|---|
| IPO Date | Feb 10, 2021 |
| CEO | Eyal Ofir |
| Left Lead | Goldman Sachs |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector |
General
Growth-oriented subsectors of the healthcare, technology, energy transition, financial and consumer sectors |
| IPO Geography | Global |
| Target Company | N/A |
| Deal Announced | N/A |
| Deal Size, $M | TBD |
| Deal Sector | TBD |
| Deal Geography | TBD |
| SEC Filings | www.sec.gov |
| Approval Vote | TBD |
| Amendment Vote | TBD |
| Closing Date | Feb 22, 2023 |
LGAC
LGACU
LGACW
| Price | |
|---|---|
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Lazard Growth Acquisition Corp. I:
- Structure and cap table
- 8 directors & officers
- 7 filings and events
- 1 underwriters
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Alexander Stern | 54 | Executive Chairman of the Board and Director |
| Eyal Ofir | 40 | Chief Executive Officer and Director |
| Mary Ann Deignan | 58 | Chief Financial Officer and Director |
| Adam Berlew | 54 | Director |
| Pierre-Yves Cros | 61 | Director |
| Philip Hadley | 58 | Director |
| Noreen Roth Henig | 55 | Director |
| Selina Tobaccowala | 54 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Goldman Sachs | BR | 50,000,000 | units |
| 50,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee | 3.50 | % |
Sign in to view more advisor data.
Filings
Sign in to view 7 filings.